BBSRC and NC3Rs invest in next generation non-animal technologies

BBSRC and NC3Rs have invested £4.7 million in 24 new projects focusing on alternatives to in vivo models in bioscience research.

The Biotechnology and Biological Sciences Research Council (BBSRC) and National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) have invested £3.7 million to develop the next generation of non-animal technologies (NATs).

UK Research and Innovation invested a further £1 million as part of its commitment to secure better health, ageing and wellbeing through the development of non-animal technologies to support ageing research.

The 24 projects awarded funding cover a wide range of disciplines and model types, including:

• human stem cell organoid systems
• vascularised organ-on-a-chip models
• novel in silico frameworks

Projects will focus either on the development of new NATs or enhancing confidence in existing technologies by improving the physiological relevance, throughput or breadth of application of current models.

Read the entire news report here. Published on the 16th of December 2022.